A study of Avacopan in atypical hemolytic uremic syndrome (aHUS)

Trial Profile

A study of Avacopan in atypical hemolytic uremic syndrome (aHUS)

Planning
Phase of Trial: Phase III

Latest Information Update: 20 Jan 2017

At a glance

  • Drugs Avacopan (Primary)
  • Indications Haemolytic uraemic syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2017 New trial record
    • 09 Jan 2017 According to a ChemoCentryx media release, if successful, the study could support registration of the drug.
    • 09 Jan 2017 According to a ChemoCentryx media release, this study is expected to initiate in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top